When.com Web Search

  1. Ads

    related to: tumor marker for prostate cancer screening guidelines

Search results

  1. Results From The WOW.Com Content Network
  2. Tumor marker - Wikipedia

    en.wikipedia.org/wiki/Tumor_marker

    No screening test is wholly specific, and a high level of tumor marker can still be found in benign tumors. The only tumor marker currently used in screening is PSA (prostate-specific antigen). Diagnostics; Tumor markers alone can't be used for diagnostic purposes, due to lack of sensitivity and specificity. [5]

  3. Prostate cancer screening - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer_screening

    EpiSwitch® PSE is a blood test used for screening and diagnosing prostate cancer utilizing epigenetic markers to identify specific changes in regulatory looping structures (chromosome conformation signatures) associated with prostate cancer. Used in conjunction with a PSA test, the PSE test boosts accuracy from 55% to 94% offering a more ...

  4. Prostate cancer screening guidelines may fail to address ...

    www.aol.com/news/prostate-cancer-screening...

    Relaxed PSA screening guidelines may be leading to more late-stage cancer diagnoses, and the current recommendations updated to address this concern might preferentially serve white men, a new ...

  5. Cancer biomarker - Wikipedia

    en.wikipedia.org/wiki/Cancer_biomarker

    A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule." [18] In cancer research and medicine, biomarkers are used in three primary ways: [19] To help diagnose conditions, as in the case of identifying early stage cancers (diagnostic)

  6. Cancer screening - Wikipedia

    en.wikipedia.org/wiki/Cancer_screening

    When PSA screening began in the 1980s, cases of prostate cancer rose by 26% between 1986-2005, with the most affected age group being men under the age of 50. [37] Prostate cancer is a heterogeneous disease, and the cancer will grow aggressively in approximately 1 in 3 cases. Therefore there is a risk of overdiagnosing and overtreating, this ...

  7. TNM staging system - Wikipedia

    en.wikipedia.org/wiki/TNM_staging_system

    G (1–4): the grade of the cancer cells (i.e. they are "low grade" if they appear similar to normal cells, and "high grade" if they appear poorly differentiated) S (0–3): elevation of serum tumor markers; R (0–2): the completeness of the operation (resection-boundaries free of cancer cells or not) Pn (0–1): invasion into adjunct nerves